VanEck Australian Floating Rate ETF vs Mesoblast Limited — how do they compare? VanEck Australian Floating Rate ETF trades at $50.93, while Mesoblast Limited trades at $16.68 (market cap $2.21B). Which is the better fit depends on your goals.
| FLOT | MESO | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $51.09 | $20.96 |
52-Week Low | $50.72 | $12.88 |
Market Cap | — | $2.21B |
Enterprise Value | — | $2.21B |
Trailing returns across standard periods
FLOT provides exposure to a diversified portfolio of Australian dollar-denominated floating rate notes. It tracks the Bloomberg AusBond Credit FRN 0+ Yr Index, focusing on high-quality, investment-grade bonds from top Australian banks and financial institutions.
Read more on FLOT →Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →